Narmada Gelatines Ltd
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
- Market Cap ₹ 209 Cr.
- Current Price ₹ 345
- High / Low ₹ 416 / 300
- Stock P/E 7.65
- Book Value ₹ 209
- Dividend Yield 2.90 %
- ROCE %
- ROE 14.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | TTM | |
|---|---|---|
| 189 | 203 | |
| 164 | 168 | |
| Operating Profit | 25 | 35 |
| OPM % | 13% | 17% |
| 2 | 4 | |
| Interest | 1 | 1 |
| Depreciation | 2 | 2 |
| Profit before tax | 24 | 35 |
| Tax % | 24% | |
| 18 | 27 | |
| EPS in Rs | 29.80 | 45.13 |
| Dividend Payout % | 34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 18% |
| 3 Years: | 9% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 6 | 6 |
| Reserves | 114 | 120 |
| 13 | 12 | |
| 27 | 25 | |
| Total Liabilities | 160 | 164 |
| 33 | 33 | |
| CWIP | 7 | 8 |
| Investments | 42 | 43 |
| 78 | 80 | |
| Total Assets | 160 | 164 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 17 | |
| -29 | |
| 5 | |
| Net Cash Flow | -6 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 48 |
| Inventory Days | 155 |
| Days Payable | 57 |
| Cash Conversion Cycle | 146 |
| Working Capital Days | 88 |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count ・Standalone data |
|
||||||||||
| Installed Capacity - Gelatine MT per annum ・Standalone data |
|||||||||||
| Sales Volume - Di-calcium Phosphate (DCP) MT ・Standalone data |
|||||||||||
| Sales Volume - Gelatine MT ・Standalone data |
|||||||||||
| Installed Capacity - Di-calcium Phosphate (DCP) MT per annum ・Standalone data |
|||||||||||
| Production Volume - Di-calcium Phosphate (DCP) MT ・Standalone data |
|||||||||||
| Production Volume - Gelatine MT ・Standalone data |
|||||||||||
| Production Volume - Ossein MT ・Standalone data |
|||||||||||
| Installed Capacity - Ossein MT per annum ・Standalone data |
|||||||||||
| Capacity Utilization - Gelatine % ・Standalone data |
|||||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
6 Mar - CARE Edge reaffirmed Narmada Gelatines' ratings: Term loan ₹31.35cr CARE BBB; Stable; CC ₹20.00cr CARE A3+ (06-Mar-2026)
-
Opening Of Special Window For Transfer And Dematerialization Of Physical Securities
2 Mar - SEBI opens Feb 5, 2026–Feb 4, 2027 window for transfer/demat of pre-April 1, 2019 securities; one-year lock-in.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Feb - Newspaper Advertisement - Disclosure under Regulation 30 and 47 of of SEBI (LODR) Regulations, 2015, extracts of Un-audited Financial Results for the quarter and nine …
- Un-Audited Financial Results Of The Company For The Quarter Ended 31St December, 2025 12 Feb
-
Board Meeting Outcome for Board Meeting Outcome For Approval Of Un-Audited Financial Results For The Quarter Ended 31St December, 2025.
12 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water